Table 2.
Scale Parameter α | Shape Parameter β | ||||||
---|---|---|---|---|---|---|---|
Group Mean | Post Hoc Test | Group Mean | Post Hoc Test | ||||
Group | ± SD (range), a.u. | P | ± SD (range), a.u. | P | |||
Mean map value | Control | 39 ± 3 (34–47) | C vs. S | 0.037 | 4.1 ± 0.5 (3.5–5.8) | C vs. S | 1.00 |
Subclinical | 43 ± 4 (36–51) | S vs. KC | 0.020 | 4.1 ± 0.6 (2.3–5.5) | S vs. KC | 1.00 | |
Keratoconus | 47 ± 5 (35–59) | KC vs. C | <0.001 | 3.9 ± 0.4 (3.1–4.7) | KC vs. C | 0.53 | |
Mean value in Q4 | Control | 41 ± 2 (38–47) | C vs. S | <0.001 | 4.3 ± 0.4 (3.8–5.8) | C vs. S | 1.00 |
Subclinical | 50 ± 4 (44–53) | S vs. KC | 1.00 | 4.1 ± 0.6 (2.4–5.5) | S vs. KC | 0.010 | |
Keratoconus | 50 ± 1 (44–59) | KC vs. C | <0.001 | 4.7 ± 0.7 (3.5–6.8) | KC vs. C | 0.097 |
The group mean of the variable used for the ROC analysis (i.e., values in the fourth quartile [Q4] in each corneal map) is also included. Comparisons within groups were studied using one-way analysis of variance with Bonferroni adjustment for multiple comparisons. The corresponding post hoc test (multiple comparisons) is shown. Numbers in bold indicate a statistically significant difference. C, control; S, subclinical keratoconus; KC, clinical keratoconus.